Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Exploring the current landscape of chitosan-based hybrid nanoplatforms as cancer theragnostic.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Exploring the current landscape of chitosan-based hybrid nanoplatforms as cancer theragnostic.
Exploring the current landscape of chitosan-based hybrid nanoplatforms as cancer theragnostic. Carbohydr Polym. 2024 Feb 15; 326:121644.
View in:
PubMed
subject areas
Chitosan
Drug Carriers
Drug Delivery Systems
Humans
Nanoparticles
Neoplasms
authors with profiles
Pankaj Kumar Singh